These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 32688448)
1. Colonic motility in patients with type 1 diabetes and gastrointestinal symptoms. Klinge MW; Haase AM; Mark EB; Sutter N; Fynne LV; Drewes AM; Schlageter V; Lund S; Borghammer P; Krogh K Neurogastroenterol Motil; 2020 Dec; 32(12):e13948. PubMed ID: 32688448 [TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal symptoms and cardiac vagal tone in type 1 diabetes correlates with gut transit times and motility index. Wegeberg AL; Brock C; Ejskjaer N; Karmisholt JS; Jakobsen PE; Drewes AM; Brock B; Farmer AD Neurogastroenterol Motil; 2021 Jan; 33(1):e13885. PubMed ID: 32573076 [TBL] [Abstract][Full Text] [Related]
3. The Wireless Motility Capsule: a One-Stop Shop for the Evaluation of GI Motility Disorders. Saad RJ Curr Gastroenterol Rep; 2016 Mar; 18(3):14. PubMed ID: 26908282 [TBL] [Abstract][Full Text] [Related]
4. Wireless capsule motility: comparison of the SmartPill GI monitoring system with scintigraphy for measuring whole gut transit. Maqbool S; Parkman HP; Friedenberg FK Dig Dis Sci; 2009 Oct; 54(10):2167-74. PubMed ID: 19655250 [TBL] [Abstract][Full Text] [Related]
5. Measurement of transit disorders in different gastrointestinal segments of patients with diabetes mellitus in relation to duration and severity of the disease by use of the metal-detector test. Folwaczny C; Hundegger K; Volger C; Sorodoc J; Kühn M; Tatsch K; Landgraf R; Karbach U Z Gastroenterol; 1995 Sep; 33(9):517-26. PubMed ID: 8525655 [TBL] [Abstract][Full Text] [Related]
6. The assessment of regional gut transit times in healthy controls and patients with gastroparesis using wireless motility technology. Sarosiek I; Selover KH; Katz LA; Semler JR; Wilding GE; Lackner JM; Sitrin MD; Kuo B; Chey WD; Hasler WL; Koch KL; Parkman HP; Sarosiek J; McCallum RW Aliment Pharmacol Ther; 2010 Jan; 31(2):313-22. PubMed ID: 19814743 [TBL] [Abstract][Full Text] [Related]
7. Type 1 diabetic patients with peripheral neuropathy have pan-enteric prolongation of gastrointestinal transit times and an altered caecal pH profile. Farmer AD; Pedersen AG; Brock B; Jakobsen PE; Karmisholt J; Mohammed SD; Scott SM; Drewes AM; Brock C Diabetologia; 2017 Apr; 60(4):709-718. PubMed ID: 28105520 [TBL] [Abstract][Full Text] [Related]
9. Gastric Emptying Time and Volume of the Small Intestine as Objective Markers in Patients With Symptoms of Diabetic Enteropathy. Klinge MW; Sutter N; Mark EB; Haase AM; Borghammer P; Schlageter V; Lund S; Fleischer J; Knudsen K; Drewes AM; Krogh K J Neurogastroenterol Motil; 2021 Jul; 27(3):390-399. PubMed ID: 34210904 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic and clinical utility of the wireless motility capsule in children: A study in patients with functional gastrointestinal disorders. Rodriguez L; Heinz N; Colliard K; Amicangelo M; Nurko S Neurogastroenterol Motil; 2021 Apr; 33(4):e14032. PubMed ID: 33184926 [TBL] [Abstract][Full Text] [Related]
11. MoPill a novel gastrointestinal positioning system (GPS): New technology to navigate the alimentary tract highway. Sarosiek I; Espino K; Lembo A; McCallum RW Neurogastroenterol Motil; 2024 Sep; 36(9):e14864. PubMed ID: 39038121 [TBL] [Abstract][Full Text] [Related]
13. Ambulatory assessment of colonic motility using the electromagnetic capsule tracking system. Mark EB; Poulsen JL; Haase AM; Espersen M; Gregersen T; Schlageter V; Scott SM; Krogh K; Drewes AM Neurogastroenterol Motil; 2019 Feb; 31(2):e13451. PubMed ID: 30129117 [TBL] [Abstract][Full Text] [Related]
14. Scintigraphy for evaluation of patients for GI motility disorders--the referring physician's perspective. Parkman HP Semin Nucl Med; 2012 Mar; 42(2):76-8. PubMed ID: 22293162 [TBL] [Abstract][Full Text] [Related]
15. Faster recovery of gastrointestinal transit after laparoscopy and fast-track care in patients undergoing colonic surgery. van Bree SH; Vlug MS; Bemelman WA; Hollmann MW; Ubbink DT; Zwinderman AH; de Jonge WJ; Snoek SA; Bolhuis K; van der Zanden E; The FO; Bennink RJ; Boeckxstaens GE Gastroenterology; 2011 Sep; 141(3):872-880.e1-4. PubMed ID: 21699777 [TBL] [Abstract][Full Text] [Related]
16. A randomised controlled study of the effect of cholinesterase inhibition on colon function in patients with diabetes mellitus and constipation. Bharucha AE; Low P; Camilleri M; Veil E; Burton D; Kudva Y; Shah P; Gehrking T; Zinsmeister AR Gut; 2013 May; 62(5):708-15. PubMed ID: 22677718 [TBL] [Abstract][Full Text] [Related]
17. Magnetic tracking of gastrointestinal motility. Brinck CE; Mark EB; Klinge MW; Ejerskov C; Sutter N; Schlageter V; Scott SM; Drewes AM; Krogh K Physiol Meas; 2020 Dec; 41(12):12TR01. PubMed ID: 33227727 [TBL] [Abstract][Full Text] [Related]
18. Use of wireless motility capsule to determine gastric emptying and small intestinal transit times in critically ill trauma patients. Rauch S; Krueger K; Turan A; You J; Roewer N; Sessler DI J Crit Care; 2012 Oct; 27(5):534.e7-12. PubMed ID: 22300488 [TBL] [Abstract][Full Text] [Related]
19. A randomized trial of 5-hydroxytryptamine4-receptor agonist, YKP10811, on colonic transit and bowel function in functional constipation. Shin A; Acosta A; Camilleri M; Boldingh A; Burton D; Ryks M; Rhoten D; Zinsmeister AR Clin Gastroenterol Hepatol; 2015 Apr; 13(4):701-8.e1. PubMed ID: 25148765 [TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal transit and contractility in diabetic constipation: A wireless motility capsule study on diabetes patients and healthy controls. Sangnes DA; Lundervold K; Bekkelund M; von Volkmann HL; Berentsen B; Gilja OH; Dimcevski G; Søfteland E United European Gastroenterol J; 2021 Dec; 9(10):1168-1177. PubMed ID: 34687494 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]